247 related articles for article (PubMed ID: 21123387)
41. Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium.
Singanayagam A; Zambon M; Barclay WS
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189708
[TBL] [Abstract][Full Text] [Related]
42. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.
Sleeman K; Stein DA; Tamin A; Reddish M; Iversen PL; Rota PA
Virus Res; 2009 Mar; 140(1-2):49-56. PubMed ID: 19059443
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.
Ge Q; Pastey M; Kobasa D; Puthavathana P; Lupfer C; Bestwick RK; Iversen PL; Chen J; Stein DA
Antimicrob Agents Chemother; 2006 Nov; 50(11):3724-33. PubMed ID: 16966399
[TBL] [Abstract][Full Text] [Related]
45. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis.
Lambertz RLO; Gerhauser I; Nehlmeier I; Leist SR; Kollmus H; Pöhlmann S; Schughart K
J Gen Virol; 2019 Jul; 100(7):1073-1078. PubMed ID: 31099738
[TBL] [Abstract][Full Text] [Related]
46. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
[TBL] [Abstract][Full Text] [Related]
47. Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased influenza A virus cleavage and replication.
Kesic MJ; Hernandez M; Jaspers I
Respir Res; 2012 Sep; 13(1):82. PubMed ID: 22992220
[TBL] [Abstract][Full Text] [Related]
48. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
[TBL] [Abstract][Full Text] [Related]
49. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
50. Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions.
Fabozzi G; Oler AJ; Liu P; Chen Y; Mindaye S; Dolan MA; Kenney H; Gucek M; Zhu J; Rabin RL; Subbarao K
J Virol; 2018 Sep; 92(17):. PubMed ID: 29976658
[TBL] [Abstract][Full Text] [Related]
51. Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.
Russier M; Yang G; Briard B; Meliopoulos V; Cherry S; Kanneganti TD; Schultz-Cherry S; Vogel P; Russell CJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694942
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
Rosenke K; Leventhal S; Moulton HM; Hatlevig S; Hawman D; Feldmann H; Stein DA
J Antimicrob Chemother; 2021 Jan; 76(2):413-417. PubMed ID: 33164048
[TBL] [Abstract][Full Text] [Related]
53. The hemagglutinin: a determinant of pathogenicity.
Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
[TBL] [Abstract][Full Text] [Related]
54. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
[TBL] [Abstract][Full Text] [Related]
55. Identification of amino acids in the HA of H3 influenza viruses that determine infectivity levels in primary swine respiratory epithelial cells.
Busch MG; Bateman AC; Landolt GA; Karasin AI; Brockman-Schneider RA; Gern JE; Suresh M; Olsen CW
Virus Res; 2008 May; 133(2):269-79. PubMed ID: 18329747
[TBL] [Abstract][Full Text] [Related]
56. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
57. Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture.
Whittaker GR; Straus MR
Influenza Other Respir Viruses; 2020 Mar; 14(2):189-195. PubMed ID: 31820577
[TBL] [Abstract][Full Text] [Related]
58. Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.
Kesic MJ; Meyer M; Bauer R; Jaspers I
PLoS One; 2012; 7(4):e35108. PubMed ID: 22496898
[TBL] [Abstract][Full Text] [Related]
59. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
60. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
